Evidence map›Paper›PMID 36722791›Full record

ArticleLeukemia & lymphoma2023

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.

Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner, Annie Im, Kathleen A Dorritie, Alison Sehgal and 5 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia & lymphoma, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Konstantinos LontosUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-0216-3818
Anastasia TsagianniUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Mounzer AghaUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Anastasios RaptisUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Jing-Zhou HouUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Rafic FarahUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Robert L RednerUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Annie ImUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Kathleen A DorritieUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Alison SehgalUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-3954-7401
James RossettiUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Nidhi AggarwalDepartment of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Melissa SaulDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Michael BoyiadzisUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Nathanael G BaileyDepartment of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0002-6747-680X
UPMC Hillman Cancer Center · USUniversity of Pittsburgh · USThe University of Texas MD Anderson Cancer Center · US

Funding

NRSA Training CoreTL1TR001858 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RADOMSKI, THOMAS, RUBIO, DORIS M · 2016 to 2025
$11.1M
NCATS NIH HHS TL1 TR001858
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bone MarrowBone Marrow CellsBiopsyHumansPrognosisRemission Induction

Identifiers

PMID36722791
PMCPMC10257893
OpenAlexW4318753647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.